)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
The Japanese automaker aims to sell 100,000 vehicles in India and export another 100,000 annually by FY28, with the new Tekton SUV expected to drive growth
Executives say move unlikely to affect prices of IVF procedures
BMW Group India said every Re 1 depreciation in the rupee against the euro trims its profit margin by about 1 per cent, prompting the company to consider further price increases
Tata Motors Passenger Vehicles aims to sell more than 1.2 million vehicles annually by FY31, with EVs contributing over 30 per cent of volumes and EBITDA margins in double digits
Mercedes-Benz India expects record sales in 2026, banking on robust demand and a healthy order pipeline despite further price hikes driven by the appreciation of the euro
India's EV market crossed 12 per cent of overall vehicle retail sales for the first time in June, driven by record electric two-wheeler sales and broad-based growth across segments
Anand Mahindra says India is well placed to bridge geopolitical blocs, while Group CEO Anish Shah says artificial intelligence will power the conglomerate's next phase of growth
Hospitals across Mumbai have maintained routine medical services despite heavy rains, but doctors report rising seasonal illnesses and slower ambulance movement due to waterlogging
Suzuki Motor Corporation will expand the capacity of its newly inaugurated Kharkhoda manufacturing facility in phases, reinforcing its long-term commitment to India
Harrier EV demand is nearly double current production capacity as Tata Motors targets monthly output of 70,000 vehicles with expanded manufacturing and supplier ramp-up
Chairman N Chandrasekaran says the combined Tata Motors-Iveco business could lift annual revenue to $35-40 billion in five years, boosting global scale and technology
Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, injector devices and glass cartridges
Following the completion of the transaction, Pivot Path will be reclassified from a wholly owned subsidiary to an associate company of Strides
Commercial vehicle wholesales rose 13.5 per cent in May, supported by GST cuts and a favourable base, but ICRA expects growth to moderate to 4-6 per cent in FY27
The joint venture will invest over $20 million in a pharmaceutical manufacturing facility in Sri Lanka to boost local drug production and reduce reliance on imports
USFDA completed a pre-license inspection of the Hyderabad facility and issued a Form 483 with seven observations, which the company said it will address within the stipulated timeline
Tata Motors says commercial vehicle electrification is nearing a tipping point, driven by improving economics, localisation and policy support
Tata Motors to begin pilot trials of trucks running on 2% isobutanol-blended diesel next quarter as India explores alternative fuels to cut oil imports
Biocon, Zydus, Dr Reddy's are among companies positioning for one of the largest biosimilar launches for cancer treatment
The drugmaker said it is monitoring its systems and maintaining normal operations after reports that a hacking group claimed to have stolen and published company data